ClinicalTrials.govpublic full text
Clinical Outcomes, Compliance and Effectiveness of Switching From Infliximab or Etanercept to Adalimumab in Patients With Active Rheumatoid Arthritis (RA). A Multicenter Post-Marketing Observational Study in Routine Clinical Use
rheumatoid arthritis, anti-tnf, adalimumab, infliximab, etanercept, observational
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 895250
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.